advertisement
Katz LJ 40
Showing records 1 to 25 | Display all abstracts from Katz LJ90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Bonafede L
Journal of Glaucoma 2020; 29: 851-856
90182 iStent inject®: A Comprehensive Survey of the Literature
Shalaby WS
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Shalaby WS
Ophthalmology. Glaucoma 2021; 4: 182-192
90182 iStent inject®: A Comprehensive Survey of the Literature
Shalaby WS
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Saheb H
Current Eye Research 2020; 0: 1-8
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Shalaby WS
Ophthalmology. Glaucoma 2021; 4: 182-192
90182 iStent inject®: A Comprehensive Survey of the Literature
Shalaby WS
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Shalaby WS
Ophthalmology. Glaucoma 2021; 4: 182-192
90182 iStent inject®: A Comprehensive Survey of the Literature
Jia J
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Myers JS
Ophthalmology. Glaucoma 2021; 4: 182-192
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Sanvicente CT; Sanvicente CT
Journal of Glaucoma 2020; 29: 851-856
89941 Current and new pharmacotherapeutic approaches for glaucoma
Shankar V
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Donnenfeld ED
Current Eye Research 2020; 0: 1-8
89941 Current and new pharmacotherapeutic approaches for glaucoma
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
90058 Beliefs and Attitudes of Ophthalmologists Regarding SLT as First Line Therapy for Glaucoma
Hark LA
Journal of Glaucoma 2020; 29: 851-856
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Solomon KD
Current Eye Research 2020; 0: 1-8
90182 iStent inject®: A Comprehensive Survey of the Literature
Katz LJ
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Razeghinejad R
Ophthalmology. Glaucoma 2021; 4: 182-192
90772 Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma
Voskanyan L
Current Eye Research 2020; 0: 1-8
90182 iStent inject®: A Comprehensive Survey of the Literature
Lee D
Journal of Cataract and Refractive Surgery 2021; 47: 385-399
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Katz LJ
Ophthalmology. Glaucoma 2021; 4: 182-192
89941 Current and new pharmacotherapeutic approaches for glaucoma
Katz LJ
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040
